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Abstract: While various volatile organic compounds (VOCs) are known to show neurotoxic 
effects, the detailed mechanisms of the action of VOCs on the autonomic nervous system 
are not fully understood, partially because objective and quantitative measures to indicate 
neural abnormalities are still under development. Nevertheless, heart rate variability (HRV) 
has been recently proposed as an indicative measure of the autonomic effects. In this study, 
we used HRV as an indicative measure of the autonomic effrects to relate their values to the 
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personal concentrations of VOCs measured by a real-time VOC monitor. The measurements 
were conducted for 24 hours on seven healthy subjects under usual daily life conditions. The 
results showed HF powers were significantly decreased for six subjects when the changes of 
total volatile organic compound (TVOC) concentrations were large, indicating a suppression 
of parasympathetic nervous activity induced by the exposure to VOCs. The present study 
indicated these real-time monitoring was useful to characterize the trends of VOC exposures 
and their effects on autonomic nervous system.  
Keywords: real-time monitoring; VOCs; heart rate variability (HRV); Holter monitor 
 
1. Introduction 
Volatile organic compounds (VOCs) are of great concern because of their potential wide-ranging 
health impacts [1]. For instance, most VOCs observed in buildings are known to cause neurological  
toxicity [2] and clinical symptoms such as headaches, nausea, respiratory irritation, fatigue, complaints, 
asthma symptoms and so on [3,4]. Furthermore, some VOCs are suggested to be related to sick 
building syndrome (SBS) and/or multiple chemical sensitivity (MCS) and induce the above-mentioned 
symptoms even by exposures to the small amounts present in general environments [4-7]. Nevertheless, 
the detailed mechanisms of these effects have not been clarified yet. To elucidate these mechanisms, 
simultaneous measurements of both VOC exposures and health impacts are essential.  
In general, to assess personal exposures to VOCs, the exposure concentrations are inevitably 
averaged over several hours or days since it takes time to collect the sufficient amounts of VOCs 
necessary for subsequent analytical procedures such as gas chromatography-mass spectroscopy   
(GC-MS) analysis. However, since the personal exposures are fluctuate considerably due to personal 
activities as well as the microenvironments where the individuals are present [8,9], time-resolved 
measurements are often essential to accurately characterize the personal exposure patterns. Several 
time-resolved methods including proton transfer reaction mass spectrometry (PTR-MS) and selected 
ion flow tube-mass spectrometry (SIFT-MS) have been developed [10-13]. However, these methods 
cannot be used for personal exposure measurements because of the size of the instruments.  
A recently developed portable real-time monitor to measure VOCs could be a useful tool to 
overcome these difficulties [14,15]. Among the various kinds of portable VOC monitors, the monitor 
using a photoionization detector (PID) can detect total VOCs (TVOCs) at intervals of a few seconds, 
and the detection sensitivity by this detector was reported to range from ppb to ppm [16]. Furthermore, 
a wide range of VOC species can be detected by PID. For instance, in the cases of a 10.6-eV UV lamp, 
more than one hundred VOC species including benzene, trichloroethylene, tetrachloroethylene, toluene, 
xylene, p-dichlorobenzene, ethylbenzene, styrene and so on are detectable as TVOCs. Therefore, the 
PID-based VOC monitor is expected to be a good tool to accurately measure time-resolved personal 
VOC exposure data for human subjects.  
Meanwhile, heart rate variability (HRV), which reflects the function of an autonomic nervous 
system, is often measured to evaluate health impacts caused by various environmental factors. Since 
the heart rates are regulated by an autonomic nervous system, the measurement of HRV can directly Int. J. Environ. Res. Public Health 2010, 7          
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indicate the status of the autonomic nervous system. By analyzing the frequency domains of the RR 
intervals (that is, intervals between adjacent R waves resulting from sinus node depolarizations), 
typical spectral peaks appear in the ranges of low frequency (LF, 0.04–0.15 Hz) and high frequency 
(HF, 0.15–0.4 Hz) in the power spectrum density [17]. While HF power mainly reflects 
parasympathetic activity, LF power primarily reflects sympathetic activity with some parasympathetic 
input. The relative power of LF to HF components (that is, power ratio of LF to HF) is often used as an 
indicator of sympathetic nervous activity, too [17,18].  
To date, numerous studies have been conducted to investigate the relationships between HRV and 
diseases and/or clinical symptoms [19-22]. Since a lightweight portable electrocardiogram (ECG) 
Holter monitor has become available recently, HRV has been widely measured for individuals along 
with measurements of various environmental factors such as airborne particulate matter [23-28], 
carbon oxide [26], environmental tobacco smoke [29], electromagnetic fields and so on [30]. To our 
knowledge, however, no study has ever been conducted to measure HRV along with personal   
VOC exposures.  
The present study aims to report a methodology to evaluate health impacts caused by personal 
exposures to VOCs by using the abovementioned VOC and ECG monitors. We used the PID-based 
VOC monitor and the ECG Holter monitor to measure personal TVOC exposures and HRV, 
respectively. Since these monitors are portable and capable of obtaining time-resolved data, the   
real-time simultaneous monitoring of both personal VOC exposures and HRV becomes possible. In 
this study, we analyzed the time-series data of the personal VOC exposure and HRV of seven normal 
individuals and examined the relationship between these two variables.  
2. Method 
2.1. Study Design 
This study was designed to simultaneously monitor personal VOC concentrations and HRV for 
seven normal subjects under usual daily life conditions. The measurements were conducted from 
December 2006 to January 2007. The subjects were requested to wear the Holter monitor, carry the 
VOC monitor and record time-activity logs during monitoring. This study was approved by the Human 
Ethical Committee of the Kitasato Institute Hospital. 
2.2. Subjects 
In this study, seven human subjects including four adult males and three adult females were asked 
to participate in our monitoring campaigns. The procedure was explained and informed consent was 
obtained from all the subjects. Among them, six subjects were recruited from the members of the 
laboratory of the University of Tokyo and the remaining one subject was recruited by public 
announcement. They were normal individuals with no previous record of diagnosed SBS or MCS. The 
ages of the subjects ranged from 22 to 54 years (32 ± 13 years).  Int. J. Environ. Res. Public Health 2010, 7          
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2.3. HRV Analysis 
The continuous electrocardiogram (ECG) data were recorded for 24 hours by the Holter monitor 
[FM-150, 49.5(W) × 44.5(H) × 14.7(D) mm, 40 g, FUKUDA DENSHI, Japan]. The subjects were 
instructed how to attach four electrodes in proper positions: in the upper segment of the sternum as  
ch1/2 (−), the lower segment of the sternum as ch2 (+), the V5 position as ch1 (+) and theV5R position 
as reference. The Holter monitor was worn around his/her necks and was fixed on a lower abdomen 
with a seal to avoid data noise. The subjects were asked to go about their normal daily life activities 
during the measurement period, but without taking a bath to prevent the failure of the equipment. The 
ECG data were collected at 125 Hz and recorded on removable multimedia cards.  
In the analysis of HRV, RR intervals of ECG were used. According to Task Force, 250-Hz is 
recommended as sampling rate, while a lower sampling rate may behave satisfactorily only if an 
algorithm of interpolation is used [17]. In this study, cubic spline interpolation was conducted to RR 
curve of ECG. After interpolation, HF and LF power were calculated in each 10-sec interval by the 
Gabor wavelet transform, which is a new methodology for frequency analysis in quantifying HRV in 
non-stationary conditions [31]. The Cubic spline interpolation and the Gabor wavelet transform 
analysis was conducted using Fluclet WT (Dainippon Sumitomo Pharma, Japan), a software 
implementing the Gabor transform especially for circulatory dynamics parameters. The calculated HF 
and LF power were averaged over 5-min interval according to the recommendation of Task Force [17]. 
As mentioned before, HF power was used as an indicator of parasympathetic activity and the power 
ratio of LF to HF (LF/HF) was used as an indicator of sympathetic activity. 
2.4. TVOC Monitoring 
The exposure concentrations of TVOCs were measured for 24 hours by a portable real-time VOC 
monitor with PID [ppbRAE, 76.2 (W) × 50.8 (H) × 218 (D) mm, 553 g, RAE systems, USA)]. The 
detector was equipped with 10.6-eV UV lamp. Before each measurement, calibrations were conducted 
using VOC-free air (pure air, G1) and 10 ppm isobutylene gas. To prevent possible psychological 
biases caused by perceiving the monitored values of the VOC monitor by the subjects, the subjects 
were blinded for the reading of the monitor by sealing on the display. In addition, to reduce the noise 
of the pump during the measurements, the monitor was put in a soundproof box filled with cotton. The 
subjects were requested to put the monitor into a bag and carry and/or keep it aside. 
The monitor can measure TVOC concentrations every second, but since the data logging capacity is 
limited, the averaged concentrations of 20 sec or 1 min intervals were recorded during the 24-hour 
measurement periods. At the same time, the monitor was configured to record the maximum 
concentrations and minimum concentrations for each interval. The recorded values were isobutylene 
equivalent concentration in ppb. Isobutylene is used to calibrate PIDs because its responsiveness by 
PID is relatively moderate among the VOCs generally observed in the general environment. 
Furthermore, it is easy to handle since it is non-toxic and non-flammable at the low concentration used 
for calibration [16]. However, since isobutylene is not a major component in the general environment, 
it is unrealistic to denote TVOC concentrations as isobutylene equivalent concentrations. Instead, we 
converted isobutylene equivalent concentrations to toluene equivalent concentrations, a   Int. J. Environ. Res. Public Health 2010, 7          
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commonly-used expression for TVOCs, using a correction factor. Correction factor is used to adjust 
the sensitivity of PID to convert isobutylene equivalent concentrations to toluene equivalent 
concentrations of measured gaseous substances. Toluene equivalent concentration is calculated using 
the follow equation:  
toluene e isobutylen toluene CF C C         (1) 
where Ctoluene [ppb] is toluene equivalent concentration of TVOCs, Cisobutylene [ppb] is isobutylene 
equivalent concentration of TVOCs and CFtoluene is the correction factor for toluene (=0.5 [16]). 
Moreover, Ctoluene was converted from ppb to µg/m
3 with the temperature adjustment. Temperatures 
were measured by thermohygrometer (HOBO, Onset Computer Corporation, USA). These values were 
averaged over each 5-min interval. Relative humidity (RH) was also measured by the 
thermohygrometer. In addition to analyzing the absolute concentrations of TVOCs, we analyzed the 
changes of TVOC concentrations within a certain interval of measurement period. In this study, the 
changes of TVOC concentrations for each 5-min interval, expressed as ΔTVOC (µg/m
3), were defined 
as the difference of the minimum and maximum concentrations measured in that 5-min interval. 
ΔTVOC, which is an absolute value of the concentration difference, cannot distinguish whether it was 
increased or decreased between the consecutive time intervals. Here we defined d+TVOC and 
d−TVOC if the difference was positive and negative, respectively.  
2.5. Time-Activity Pattern 
The time-activity patterns in each 5-min interval were recorded by the subjects. The subjects were 
requested to select their activities and environments from the following alternatives shown in Figure 1; 
six kinds of personal activities including sitting, standing, walking, exercising, eating and sleeping and 
4 kinds of microenvironments including home, office, other indoor and outdoor. 
Figure 1. An excerpt of a time-activity log sheet. 
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3. Results and Discussion 
3.1. Time Series Data 
Figure 2 shows an example of the time series data. TVOC concentrations varied notably in this 
measurement period (mean ± SD, 354 ± 349, range 63–1,447 µg/m
3) and several TVOC peak 
concentrations were observed. The peaks observed at 8:40 and 21:05 were suspected to be of outdoor 
origin because the subject was outdoors according to the time-activity log. Meanwhile, the peaks 
observed between 22:00 and 24:00 were likely due to cooking activities. Unlike the traditional   
time-integrated measurements, the time-resolved measurements can provide considerable information 
regarding personal VOC exposures. Furthermore, using with the time-resolved time-activity data, the 
trends of the personal exposures can be accurately characterized and the linkages between the time 
activities and the TVOC concentrations can be effectively assessed.  
Figure 2. An example of time-series data of TVOC concentration and HRV (Subject a). 
 
In Figure 2, HRV parameters also fluctuated through the measurement period. In particular, Figure 
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these activities (i.e., exercising, eating and sleeping) and the time the effect continue (i.e., 15 min after 
exercising, 1 hour after eating) from the analyses.  
3.2. Statistical Summary 
Table 1 shows a summary of the exposure concentrations of TVOCs and HRV parameters observed 
for all subjects studied in this study. The concentrations of TVOCs measured are in the ranges 
normally observed in exhaled breath [35-37]. The results indicate the exposure concentrations differed 
by each microenvironment. The results also indicate the inter-individual variation in the exposure 
concentrations at office was relatively small probably because 6 subjects stayed in the offices of the 
same building.  
Table 1. Summary of TVOC exposure concentrations and HRV parameters.  
 n 
a  Mean ± SD 
b CV  (%) 
c 
TVOC exposure concentration (µg/m
3)      
Total  7  176 ± 130  74 
Home  7  299 ± 267  89 
Office  6  99 ± 21  21 
Other indoor  5  197 ± 118  60 
Outdoor  6  154 ± 72  47 
HRV      
HF (msec
2)  7  104.2 ± 89.0  85 
LF/HF  7  15.3 ± 19.0  124 
a Sample size 
b Standard deviation 
c Coefficient of variance 
3.3. Bivariate Analysis 
Spearman rank correlation coefficients were calculated by using JMP7 (SAS) to assess the 
relationships between TVOC exposures and HRV parameters measured within the same 5-min 
intervals. Table 2 shows a summary of the correlations for all subjects. The sex and age of these 
subjects are listed in Table 2. The significant negative correlations between ΔTVOC and HF were 
observed in six out of seven subjects, suggesting the changes of TVOC concentrations in 5-min were 
associated with the decrease of the activity of parasympathetic nervous. Meanwhile, one out of seven 
subjects showed significant negative correlations between TVOC concentrations and HF. Based on 
these results, the HF decreases were more likely due to the changes of TVOC concentrations rather 
than the absolute values of TVOC concentrations. The significant positive correlations were observed 
between ΔTVOC and LF/HF in five subjects, too, suggesting the changes of TVOC concentrations in 
5-min were associated with the enhancement of the activity of the sympathetic nervous. Despite the 
difference of sex and age, these tendencies, negative correlation with ΔTVOC and HF and positive 
correlation of ΔTVOC and LF/HF, were observed excluding Subject f, whose correlation of ΔTVOC 
and LF/HF was negative. As a result, ΔTVOC could be a potential candidate to evaluate the influence 
of VOC exposures on the autonomic nervous system.  Int. J. Environ. Res. Public Health 2010, 7          
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At the same time, the tendency of negative correlation between d+TVOC and HF (seven subjects) 
and the tendency of positive correlation between d−TVOC and HF (seven subjects) were observed. 
Moreover, the tendency of positive correlation between d+TVOC and LF/HF (five subjects) and the 
tendency of negative correlation between d−TVOC and LF/HF (five subjects) were observed. These 
tendencies suggested that TVOC concentration increases and decreases promote different effects on 
the successive HRV parameters. In contrast, the consistent tendencies were not observed between 
temperature and RH and HRV. 
For other pollutants, decreases of HRV parameters with increased pollutant concentration were 
often observed [23-29]. In the case of submicrometer particles (size range 0.02–1 µm), both immediate 
effects such as direct myocardial effects and cumulative effects such as increase blood coagulation by 
deposition of ultrafine particles in the alveoli were suggested [24]. The mechanism of TVOC effect on 
nerve system is not clear, but pollutants including TVOCs, which are classified as environmental 
stressor, may generally change of HRV.  
Table 2. Correlation between TVOC exposure and HRV.  
 Subjects 
−
c +
d 
 a  b  c  d  e  f  g 
Sex (M: male, F: female)  M  M  F  M  F  M  F 
Age (years)  24  22  22  23  48  33  54 
TVOC vs HF  −0.41**
a −0.04  −0.00 0.02  −0.15  −0.01  −0.08   6(1)  1(0)
ΔTVOC vs HF  −0.27**  −0.63** −0.26** −0.08  −0.19*
b −0.32**  −0.26 **  7(6)  0(0)
d+TVOC vs HF  −0.11  −0.53** −0.15  −0.06  −0.04  −0.12  −0.43 **  7(2)  0(0)
d−TVOC vs HF  0.41**  0.66** 0.18  0.16  0.29*  0.23  0.33  **  0(0)  7(4)
TVOC vs LF/HF  0.37**  0.05  −0.16* 0.15  0.10  0.01 −0.17 *  2(2)  5(1)
ΔTVOC vs LF/HF  0.20*
b 0.39** 0.07  0.18*  0.18*  −0.27** 0.36 **  1(1) 6(5)
d+TVOC vs LF/HF  0.15  0.28*  −0.00 0.24*  0.14 −0.18 0.46  **  2(0)  5(3)
d−TVOC vs LF/HF  −0.30*  −0.46** 0.01  −0.18  −0.07 0.13  −0.45 **  5(3)  2(0)
Temperature vs HF  0.64**  −0.14  −0.15 0.07  −0.20 0.10  0.14    3(0)  4(1)
RH vs HF  −0.51** 0.11  −0.08  −0.00 0.29 −0.00 0.10    4(1)  3(0)
Temperature vs LF/HF  −0.44** 0.14  0.17* −0.05  −0.00 0.30**  −0.25 **  4(2)  3(2)
RH vs LF/HF  0.31**  −0.07  −0.01 0.07 0.00 −0.21**  −0.35 **  4(2)  3(1)
a Spearman rank correlation, p < 0.01 
b Spearman rank correlation, p < 0.05 
c Numbers of the subjects showing negative correlation (significant) 
d Numbers of the subjects showing positive correlation (significant) 
 
Since these correlations might also be affected by other unknown confounding factors such as 
psychological stress, climate conditions, other environmental factors and so on, future studies will be 
necessary to further elucidate the underlying causal mechanisms between these two variables. 
However, our findings suggest the possibility of the some kind of reaction to VOCs of human subjects, 
even normal subjects who experience no subjective symptoms. 
Since different VOC species may have different degree of impacts on HRV, using TVOCs to study 
the potential autonomic defect of VOC exposure has its limitations. For example, because the 
compositions of VOCs might differ in each microenvironment, the health effects might also differ. To Int. J. Environ. Res. Public Health 2010, 7          
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adjust for such differences, the correlations between TVOC exposures and HRV parameters were 
investigated for each microenvironment (i.e., home, office, other indoor and outdoor). Table 3 shows 
the ranges and medians of the correlation coefficients and the numbers of the subjects showing 
significant correlations between TVOC exposure and HRV by each environment (Spearman rank 
correlation coefficients, p < 0.05). In indoor environments such as home, office and other indoors 
locations, the ranges of the correlation coefficients between ΔTVOC and HF were smaller than those 
between TVOC concentration and HF and the median values were negative. In the case of the 
correlation coefficients between ΔTVOC and LF/HF, the ranges were not always smaller than those 
between TVOC and LF/HF, but the median values were positive. Moreover, the significant negative 
correlations between ΔTVOC and HF were observed in 2–4 subjects in indoor environments. Thus, the 
correlations between ΔTVOC and HRV parameters observed indoors were more distinctive than those 
observed outdoors. Although the underlying mechanisms remain to be unknown, the present data 
suggest indoor VOCs had more influence on the autonomic nervous system than outdoor VOCs.  
Table 3. Range and median of correlation coefficients and number of the subjects showing 
significant correlation between TVOC exposure and HRV (Spearman rank correlation,   
p < 0.05). 
  Home (n = 7)  Office (n = 6)  Other indoor (n = 5)  Outdoor (n = 4) 
  Range Median  − 
a + 
b Range Median −+ Range Median  − + Range  Median −+
TVOC vs HF  0.98   0.22   0  1  0.85  −0.28   40 1.11   0.19   0 0  0.63   0.17   00
ΔTVOC vs HF  0.96   −0.24   3  0  0.42  −0.26   40 1.04   −0.40   2 0  1.08   0.22   00
TVOC vs LF/HF  0.54   −0.12   1  0  0.41  0.10   02 1.31   0.09   1 0  0.62   −0.03   00
ΔTVOC vs LF/HF  0.99   0.27   0  1  0.45  0.14   12 1.34   0.34   0 2  0.80   −0.05   00
a Numbers of the subjects showing negative correlation (significant) 
b Numbers of the subjects showing positive correlation (significant)
  
4. Conclusions 
In this study, real-time measurements of personal VOC exposure and HRV under usual daily life 
conditions were conducted for several human subjects. The results indicated significant correlations 
between  ΔTVOC and HRV parameters. The methodology reported here, which is relatively 
noninvasive and easy to carry out in the field surveys, can be used to evaluate the relationships 
between VOC exposures and autonomic function continuously under usual daily life conditions. The 
present methodology could be used in the future to evaluate the health impacts caused by VOC 
exposures of MCS patients. 
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